144
0001834021
XXXXXXXX
LIVE
0001650648
4D Molecular Therapeutics, Inc.
001-39782
5858 Horton Street
Suite 455
Emeryville
CA
94608
1-510-505-2680
David Kirn
Officer
Class A Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
58333
802662.08
55244211
09/14/2026
NASD
Class A Common
12/15/2020
Acquired from issuer in private transaction
Issuer
N
58333
12/15/2020
None
N
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/03/2026
12415
124722.33
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
06/22/2026
114746
1200851.31
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
07/09/2026
42608
548177.48
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
07/10/2026
15725
189233.08
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/04/2026
26842
274596.34
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/19/2026
50000
799565
David Kirn
5858 Horton Street
Suite 455
Emeryville
CA
94608
Class A Common
08/19/2026
19076
288707.63
The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c).
09/14/2026
01/09/2026
Goldman Sachs & Co. LLC on behalf of David Kirn